These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 30391549

  • 1. A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.
    DeGregorio GA, Singer J, Cahill KN, Laidlaw T.
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1174-1180. PubMed ID: 30391549
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
    Cooper T, Greig SR, Zhang H, Seemann R, Wright ED, Vliagoftis H, Côté DWJ.
    Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
    [Abstract] [Full Text] [Related]

  • 4. A retrospective analysis of esophageal eosinophilia in patients with aspirin-exacerbated respiratory disease.
    Eid RC, Palumbo ML, Laidlaw TM, Buchheit KM, Cahill KN.
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1338-1340. PubMed ID: 30261317
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Current complications and treatment of aspirin-exacerbated respiratory disease.
    Cook KA, Stevenson DD.
    Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data.
    San Nicoló M, Högerle C, Gellrich D, Eder K, Pfrogner E, Gröger M.
    Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):445-452. PubMed ID: 31655881
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease.
    Lee RU, White AA, Ding D, Dursun AB, Woessner KM, Simon RA, Stevenson DD.
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):130-5. PubMed ID: 20674823
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunomodulatory treatments for aspirin exacerbated respiratory disease.
    Moebus RG, Han JK.
    Am J Rhinol Allergy; 2012 Aug; 26(2):134-40. PubMed ID: 22487291
    [Abstract] [Full Text] [Related]

  • 14. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC, Moreno-Paz FJ, Terán LM, Guaní-Guerra E.
    Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature.
    Rajan JP, Wineinger NE, Stevenson DD, White AA.
    J Allergy Clin Immunol; 2015 Mar; 135(3):676-81.e1. PubMed ID: 25282015
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Is aspirin desensitization indicated for the treatment recalcitrant chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease?
    Levy JM, Smith TL.
    Laryngoscope; 2017 Apr; 127(4):776-777. PubMed ID: 27813100
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.